VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RDN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RDNRadian Group Inc.
$37.81$5.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRDNQuarterly Financials

Radian Group Inc. (RDN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Radian Group Inc. (RDN) quarterly income statement — complete revenue, gross profit & net income history

RDN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue466.34M301M310.74M317.82M317.69M316.7M319.66M321.15M319.42M326.02M312.51M289.58M
Revenue Growth %46.79%-4.96%-2.79%-1.04%-0.54%-2.86%2.29%10.9%3.09%3.59%5.51%0.96%
Medical Costs & Claims107.93M13M25.05M27.72M30.33M16.52M22.61M14.31M9.09M19.27M7.67M-6.16M
Medical Cost Ratio %23.14%4.32%8.06%8.72%9.55%5.22%7.07%4.46%2.84%5.91%2.45%-2.13%
Gross Profit358.4M288M285.69M290.1M287.36M300.18M297.04M306.83M310.33M306.75M304.84M295.74M
Gross Margin %76.86%95.68%91.94%91.28%90.45%94.78%92.93%95.54%97.16%94.09%97.55%102.13%
Gross Profit Growth %24.72%-4.06%-3.82%-5.45%-7.4%-2.14%-2.56%3.75%0.08%-8.78%-17.39%-20.51%
Operating Expenses184.74M86.5M87M115.09M98.92M111.05M82.74M118.71M111.68M126.94M103.86M113.06M
OpEx / Revenue %39.62%28.74%28%36.21%31.14%35.07%25.88%36.97%34.96%38.94%33.23%39.04%
Depreciation & Amortization002.58M26.72M14.38M25.73M12.32M19.91M14.36M1.37M14.75M1.37M
Combined Ratio %62.76%33.06%36.06%44.93%40.68%40.28%32.96%41.42%37.81%44.85%35.69%36.92%
Operating Income173.66M201M198.69M175.01M188.44M189.13M214.31M188.12M198.65M179.82M200.98M182.68M
Operating Margin %37.24%66.78%63.94%55.07%59.32%59.72%67.04%58.58%62.19%55.15%64.31%63.08%
Operating Income Growth %-7.84%6.28%-7.28%-6.97%-5.14%5.18%6.63%2.98%-2.63%-11.55%-21.33%-29.71%
EBITDA194.26M201M201.27M201.74M202.82M214.85M226.63M208.03M213.01M181.19M215.74M184.05M
EBITDA Margin %41.66%66.78%64.77%63.48%63.84%67.84%70.9%64.78%66.69%55.58%69.03%63.56%
Interest Expense20.59M017.18M25.87M22.5M22.51M21.89M27.06M24.77M20.55M23.28M21.8M
Non-Operating Income-20.59M0-17.18M-25.87M-22.5M-22.51M-21.89M-27.06M-24.77M-20.55M-23.28M-21.8M
Pretax Income173.66M201M198.69M175.01M188.44M189.13M214.31M188.12M198.65M179.82M200.98M182.68M
Pretax Margin %37.24%66.78%63.94%55.07%59.32%59.72%67.04%58.58%62.19%55.15%64.31%63.08%
Income Tax44.2M42M45.89M33.22M43.88M40.84M47.75M36.22M46.3M37.12M44.4M36.59M
Effective Tax Rate %25.45%20.9%23.1%18.98%23.29%21.59%22.28%19.25%23.3%20.65%22.09%20.03%
Net Income124.09M155M141.44M141.8M144.56M148.29M151.89M151.9M152.35M142.69M156.58M146.09M
Net Margin %26.61%51.5%45.52%44.62%45.5%46.82%47.52%47.3%47.7%43.77%50.1%50.45%
Net Income Growth %-14.16%4.52%-6.88%-6.65%-5.12%3.92%-3%3.98%-3.42%-12.1%-21.03%-27.39%
EPS (Diluted)0.901.151.031.020.980.980.990.980.980.910.980.91
EPS Growth %-8.16%17.35%4.04%4.08%0%7.69%1.02%7.69%0%-9.9%-18.33%-20.87%
EPS (Basic)0.911.151.041.030.990.991.000.990.990.920.990.92
Diluted Shares Outstanding138.49M138M137.93M138.36M147.73M151.91M153.07M154.4M155.97M157.23M160.15M160.74M